2018
DOI: 10.1542/peds.2017-4105
|View full text |Cite
|
Sign up to set email alerts
|

Respiratory Viruses and Treatment Failure in Children With Asthma Exacerbation

Abstract: Although respiratory pathogens were not associated with higher severity on presentation, they were associated with increased treatment failure risk, particularly in the presence of respiratory syncytial virus, influenza, and parainfluenza. This supports influenza prevention in asthmatic children, consideration of pathogen identification on presentation, and exploration of treatment intensification for infected patients at higher risk of treatment failure.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
33
0
3

Year Published

2019
2019
2024
2024

Publication Types

Select...
7
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 50 publications
(37 citation statements)
references
References 32 publications
1
33
0
3
Order By: Relevance
“…However, the propensity of neutrophils to exacerbate inflammatory conditions in asthma is neither restricted to bacterial pathogens nor to the airways. Neutrophils isolated from the peripheral blood of asthmatics were found to have enhanced secretion of CXCL8 in response to the viral surrogate and TLR agonist R848 compared to non-asthmatics [134], which may provide an explanation for why patients with viral respiratory tract infections are more likely to experience treatment failures [135]. While most therapies are directed at treating eosinophil-mediated allergic asthma, options for developing neutrophil-directed asthma treatments have been investigated.…”
Section: Asthmamentioning
confidence: 99%
“…However, the propensity of neutrophils to exacerbate inflammatory conditions in asthma is neither restricted to bacterial pathogens nor to the airways. Neutrophils isolated from the peripheral blood of asthmatics were found to have enhanced secretion of CXCL8 in response to the viral surrogate and TLR agonist R848 compared to non-asthmatics [134], which may provide an explanation for why patients with viral respiratory tract infections are more likely to experience treatment failures [135]. While most therapies are directed at treating eosinophil-mediated allergic asthma, options for developing neutrophil-directed asthma treatments have been investigated.…”
Section: Asthmamentioning
confidence: 99%
“…For RSV in particular, young age in months has been reported to be a predictive factor for progression to a severe condition [13]. Moreover, RSV infection was reported to be a precipitating factor for bronchial asthma [14] and a risk factor for recurrent wheezing [15]. However, difficulty of the treatment of pediatric patients who have underlying bronchial asthma or who developed RSV infection in summer has been mentioned only in a few reports.…”
Section: Discussionmentioning
confidence: 99%
“…Viral respiratory infections remain a leading cause of asthma exacerbations, both in children and adults. The presence of any pathogen is usually associated with a higher risk of treatment failure [86]. Typically management of all asthma exacerbations includes a symptomatic treatment increasing doses of beta 2a g o n i s t s , e n h a n c i n g t h e us e o f i n h a l e d o r or a l glucocorticosteroids [87].…”
Section: Treatment Of Asthma In Regard To Viral Infectionsmentioning
confidence: 99%